A Close Look at the Diagnosis and Treatment of Patients with Retinal Vascular Disease

PROGRAM CHAIR

Judy E. Kim, MD, FARVO, FASRS

Professor, Ophthalmology and Visual Sciences
Professor, Graduate School of Biomedical Sciences
Director, Teleophthalmology and Research
Medical College of Wisconsin
Milwaukee, WI

PROGRAM OVERVIEW

This online activity targets healthcare gaps related to the diagnosis and management of diabetic retinopathy (DR), age-related macular degeneration (AMD), and retinal vein occlusion (RVO), impacting outcomes through risk stratification, diagnostic strategies, and treatment individualization with anti-VEGF agents.

• By addressing these gaps, you can assess whether your approach to DR, AMD, and RVO management through incorporation of anti-VEGF agents at timely intervals and dosing regimens – could be modified to help close these gaps.
• Expert discussion will guide you in analyzing and identifying challenges to DR, AMD, and RVO management, including barriers to treatment and ways to improve patient care.
• You will also be engaged with interactive case study questions to memorably highlight key points related to DR, AMD, and RVO diagnosis and intervention.

TARGET AUDIENCE

This activity is designed to meet the educational needs of retina specialists, ophthalmologists, optometrists, and other healthcare providers who manage patients with diabetic retinopathy, age-related macular degeneration, and/or retinal vein occlusion.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

• Identify patients who are at risk for the development and progression of DR, AMD or RVO
• Implement optimal diagnostic strategies for patients with suspected DR, AMD or RVO
• Identify the barriers and enablers to the early initiation and completion of anti-VEGF therapy in patients with DR, AMD or RVO
• Incorporate anti-VEGF therapies at optimal initiation and duration intervals into the management of patients with DR, AMD or RVO

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this online activity for a maximum of 1.0 AMA PRA Category 1 credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in the care of patients with diabetic retinopathy. CNE Credits: 1.0 ANCC Contact Hour.

CNE Accreditation Statement

Ultimate Medical Academy/CCM is accredited as a provider of nursing continuing professional education development by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded 1.0 contact hour of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG‐sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

Judy E. Kim, MD, FARVO, FASRS has received consulting fees from Adverum, Astellas, Allergan, Genentech, Novartis, and Regeneron.
Dr. Kim has received research support from Notal Vision, Optos, and Heidelberg.

CME Content Review

The content of this activity was independently peer reviewed. The reviewer of this activity has nothing to disclose.

CNE Content Review

The content of this activity was peer reviewed by a nurse reviewer.

Douglas Cox, MSN, MHA, RN

Ultimate Medical Academy/CCM – Lead Nurse Planner

The reviewer of this activity has nothing to disclose

Staff Planners and Managers

The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

• Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to d
• Christina Gallo, SVP, Educational Development of Med Learning Group, has nothing to
• Nicole Longo, DO, FACOI, Director of Medical and Scientific Services of Med Learning Group, has nothing to disclose.
• Ana Maria Albino, Senior Program Manager of Med Learning Group, has nothing to
• Daniel Dasilva, Outcomes and Accreditation Coordinator of Med Learning Group, has nothing to disclose.
• Lauren Welch, MA, VP, Accreditation and Outcomes of Med Learning Group, has nothing to
• Douglas Cox, MSN, MHA, RN, UMA/CCM – LNP, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During the course of this lecture, the faculty may mention the use of medications for both FDA‐approved and non‐approved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this online activity. To receive CME/CNE credit participants must:

1. Read the CME/CNE information and faculty disclosures.
2. Participate in the online activity.
3. Complete pre-and-post surveys and evaluation.

You will receive your certificate as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision‐making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at [email protected]

AMERICANS WITH DISABILITIES ACT

Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected].

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy‐policy/.

Copyright © 2022 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.